8-KOther Events

BOSTON SCIENTIFIC CORP 8-K Report, Corporate Update (Oct 11, 2017)

Filed October 11, 2017For Securities:BSX

Summary

Boston Scientific Corporation (BSX) has announced the successful completion of its acquisition of Apama Medical, Inc., which closed on October 10, 2017. This strategic move, first announced on October 2, 2017, is expected to have an impact on the company's earnings per share, as indicated in their forward-looking statements. Investors should note that the details of the transaction, including specific financial terms, are not disclosed in this particular 8-K filing, but a press release (Exhibit 99.1) provides further information regarding the signing of the definitive agreement. The company's management has included a standard cautionary statement regarding forward-looking statements. This highlights that actual results may differ materially from projections due to various risks and uncertainties. Investors are advised to consult BSX's most recent Annual Report (10-K) and subsequent Quarterly Reports (10-Q) for a comprehensive understanding of these potential risks.

Key Highlights

  • 1Boston Scientific (BSX) has completed the acquisition of Apama Medical, Inc.
  • 2The acquisition closed on October 10, 2017.
  • 3The definitive agreement for the acquisition was signed on October 2, 2017.
  • 4The company expects the acquisition to impact its earnings per share.
  • 5Further details on the transaction are available in the press release filed as Exhibit 99.1.
  • 6The filing includes a cautionary statement regarding forward-looking statements and potential risks.
  • 7Investors are directed to review BSX's 10-K and 10-Q filings for risk factor details.

Frequently Asked Questions

This 8-K filing announces the completion of Boston Scientific's acquisition of Apama Medical, Inc. This is a key event as acquisitions can impact a company's growth strategy, market position, and financial performance, including earnings per share.

Boston Scientific acquired Apama Medical, Inc. The transaction closed on October 10, 2017.

No, this 8-K filing does not disclose the specific financial terms of the acquisition. However, it references a press release (Exhibit 99.1) that was issued on October 2, 2017, which may contain additional details about the agreement.

Forward-looking statements are projections or predictions about future events and financial performance. They are included in filings to provide investors with management's expectations. The cautionary statement is important because it warns that actual results could differ materially from these projections due to various business risks and uncertainties.